Sun Pharmaceutical Industries Limited

Ranbaxy Laboratories, Inc.

Pulak Kumar Metia

Romi Barat Singh

Satish Kumar Jain

Anuj Kumar Fanda

Rajesh Srikrishan Shear

Ravish Sharma

Ravinder Singh

Swarna Pappu

Prabhakar Konatham

Pruthvipathy Katikaneni

Dileep Jami

Sumit Madan

Kalaiselvan Ramaraju

Ravindra Agarwal

Amit Kumar

The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.

Multi-particulate pharmaceutical composition of quetiapine

The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.

Pharmaceutical composition of doxycycline with reduced food effect

The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.

Doxycycline composition

The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.

The present invention relates to a pharmaceutical composition comprising (i) 50% to 99% of doxycycline as an immediate-release portion; (ii) 1% to 50% of doxycycline as a controlled-release portion; and (iii) one or more pharmaceutically acceptable excipients; wherein the pharmaceutical composition provides a total daily dosage of 40 mg when administered once daily. It also relates to process for preparation of the pharmaceutical composition and its use for treating rosacea.

Pharmaceutical composition of doxycycline

Growing community of inventors

Howrah, India

Pulak Kumar Metia